TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
1.15 
USD
Volume:  
6,612,819.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP Relative Valuation

-79716.3%
Upside

As of 2024-06-15, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (915.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.15 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -79716.3%.

The range of the Relative Valuation is (977.51) - (964.30) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.6x - 30.9x 30.2x
Forward P/E multiples 21.2x - 29.2x 25.2x
Fair Price (977.51) - (964.30) (915.59)
Upside -85100.6% - -83952.0% -79716.3%
1.15 USD
Stock Price
(915.59) USD
Fair Price

TNXP Relative Valuation - Historical P/E Data

Date P/E
2024-06-14 -0.03
2024-06-13 -0.03
2024-06-12 -0.03
2024-06-11 -0.06
2024-06-10 -0.07
2024-06-07 -0.10
2024-06-06 -0.11
2024-06-05 -0.15
2024-06-04 -0.15
2024-06-03 -0.16
2024-05-31 -0.16
2024-05-30 -0.16
2024-05-29 -0.17
2024-05-28 -0.16
2024-05-24 -0.17
2024-05-23 -0.17
2024-05-22 -0.18
2024-05-21 -0.18
2024-05-20 -0.18
2024-05-17 -0.19
2024-05-16 -0.18
2024-05-15 -0.18
2024-05-14 -0.17
2024-05-13 -0.17
2024-05-10 -0.17
2024-05-09 -0.18
2024-05-08 -0.17
2024-05-07 -0.19
2024-05-06 -0.19
2024-05-03 -0.18
2024-05-02 -0.17
2024-05-01 -0.17
2024-04-30 -0.17
2024-04-29 -0.17
2024-04-26 -0.16
2024-04-25 -0.16
2024-04-24 -0.16
2024-04-23 -0.15
2024-04-22 -0.15
2024-04-19 -0.16
2024-04-18 -0.15
2024-04-17 -0.15
2024-04-16 -0.15
2024-04-15 -0.14
2024-04-12 -0.16
2024-04-11 -0.16
2024-04-10 -0.17
2024-04-09 -0.18
2024-04-08 -0.18
2024-04-05 -0.17